|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - REATA PHARMACEUTICALS INC (RETA)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-04-15 Sale |
2019-04-16 2:21 pm |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $83.82 | $335,262 | 70,881 (Direct) |
View |
| 2019-04-08 Sale |
2019-04-09 5:24 pm |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
2,000 | $90.17 | $180,340 | 41,434 (Direct) |
View |
| 2019-03-19 Sale |
2019-03-21 3:23 pm |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
28,396 | $93.51 | $2,655,209 | 74,881 (Direct) |
View |
| 2019-03-15 Sale |
2019-03-19 5:32 pm |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
5,604 | $94.04 | $527,026 | 89,881 (Direct) |
View |
| 2019-03-05 Sale |
2019-03-07 5:22 pm |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
26,940 | $100.2 | $2,698,441 | 26,940 (Direct) |
View |
| 2019-03-05 Sale |
2019-03-07 5:12 pm |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
3,588 | $102 | $365,976 | 43,434 (Direct) |
View |
| 2019-03-05 Sale |
2019-03-07 5:05 pm |
REATA PHARMACEUTICALS INC | RETA | Bass James Edward Director |
5,852 | $100.3 | $586,920 | 51,479 (Indirect Direct) |
View |
| 2019-02-25 Sale |
2019-02-27 4:22 pm |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
40,367 | $91.13 | $3,678,585 | 92,967 (Direct) |
View |
| 2019-02-15 Sale |
2019-02-19 1:50 pm |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $85.44 | $341,760 | 93,881 (Direct) |
View |
| 2019-02-05 Sale |
2019-02-06 1:01 pm |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
3,000 | $80 | $240,000 | 43,646 (Direct) |
View |
| 2019-01-31 Sale |
2019-02-04 3:53 pm |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
7,000 | $80 | $560,000 | 47,511 (Direct) |
View |
| 2019-01-31 Sale |
2019-02-01 11:50 am |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,150 | $76.7 | $318,302 | 12,770 (Direct) |
View |
| 2019-01-15 Sale |
2019-01-16 4:26 pm |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $71.15 | $284,589 | 97,881 (Direct) |
View |
| 2019-01-07 Sale |
2019-01-09 4:43 pm |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
20,000 | $72.04 | $1,440,820 | 53,646 (Direct) |
View |
| 2019-01-02 Sale |
2019-01-03 2:45 pm |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,150 | $53.99 | $224,045 | 21,137 (Direct) |
View |
| 2018-12-20 Purchase |
2018-12-21 09:45 am |
REATA PHARMACEUTICALS INC | RETA | Bass James Edward Director |
888 | $52.12 | $46,287 | 54,110 (Indirect Direct) |
View |
| 2018-12-10 Purchase |
2018-12-12 5:59 pm |
REATA PHARMACEUTICALS INC | RETA | Traweek James W JR 10% Owner |
110,826 | $59.41 | $6,583,834 | 3,023,349 (Indirect Direct) |
View |
| 2018-12-10 Purchase |
2018-12-12 5:58 pm |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director, 10% Owner |
110,826 | $59.41 | $6,583,834 | 3,023,349 (Indirect Direct) |
View |
| 2018-12-10 Purchase |
2018-12-12 5:57 pm |
REATA PHARMACEUTICALS INC | RETA | CPMG Inc Director, 10% Owner |
110,826 | $59.41 | $6,583,834 | 748,253 (Indirect Direct) |
View |
| 2018-11-16 Purchase |
2018-11-19 11:57 am |
REATA PHARMACEUTICALS INC | RETA | Bass James Edward Director |
1,679 | $59.33 | $99,615 | 53,222 (Indirect Direct) |
View |
| 2018-11-07 Sale |
2018-11-08 11:16 am |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $66.97 | $318,109 | 25,287 (Direct) |
View |
| 2018-11-01 Sale |
2018-11-01 5:18 pm |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $59.48 | $282,530 | 30,037 (Direct) |
View |
| 2018-10-23 Sale |
2018-10-24 11:01 am |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
14,250 | $57.08 | $813,390 | 34,787 (Direct) |
View |
| 2018-07-25 Purchase |
2018-07-26 1:22 pm |
REATA PHARMACEUTICALS INC | RETA | Bass James Edward Director |
888 | $78.34 | $69,566 | 51,543 (Indirect Direct) |
View |
| 2018-07-23 Sale |
2018-07-25 4:06 pm |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
7,336 | $50.81 | $372,764 | 140 (Direct) |
View |
| 2018-07-05 Sale |
2018-07-09 11:16 am |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $36.62 | $173,945 | 49,037 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-04-15 Conversion |
2019-04-16 2:21 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $0 | 70,881 (Direct) |
View |
| 2019-04-15 Exercise |
2019-04-16 2:21 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $11 | 70,881 (Direct) |
View |
| 2019-04-15 Exercise |
2019-04-16 2:21 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $11 | 70,881 (Direct) |
View |
| 2019-04-15 Conversion |
2019-04-16 2:21 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $0 | 70,881 (Direct) |
View |
| 2019-04-08 Conversion |
2019-04-09 5:24 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
2,000 | $0 | 41,434 (Direct) |
View |
| 2019-04-08 Exercise |
2019-04-09 5:24 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
2,000 | $11 | 41,434 (Direct) |
View |
| 2019-04-08 Exercise |
2019-04-09 5:24 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
2,000 | $11 | 41,434 (Direct) |
View |
| 2019-04-08 Conversion |
2019-04-09 5:24 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
2,000 | $0 | 41,434 (Direct) |
View |
| 2019-03-19 Conversion |
2019-03-21 3:23 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
28,396 | $0 | 74,881 (Direct) |
View |
| 2019-03-19 Exercise |
2019-03-21 3:23 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
15,000 | $11 | 74,881 (Direct) |
View |
| 2019-03-19 Exercise |
2019-03-21 3:23 pm |
N/A 2023-06-15 |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
13,396 | $11.62 | 74,881 (Direct) |
View |
| 2019-03-19 Exercise |
2019-03-21 3:23 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
15,000 | $11 | 74,881 (Direct) |
View |
| 2019-03-19 Exercise |
2019-03-21 3:23 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
13,396 | $11.62 | 74,881 (Direct) |
View |
| 2019-03-19 Conversion |
2019-03-21 3:23 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
28,396 | $0 | 74,881 (Direct) |
View |
| 2019-03-15 Conversion |
2019-03-19 5:32 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $0 | 89,881 (Direct) |
View |
| 2019-03-15 Conversion |
2019-03-19 5:32 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
1,604 | $0 | 89,881 (Direct) |
View |
| 2019-03-15 Exercise |
2019-03-19 5:32 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $11 | 89,881 (Direct) |
View |
| 2019-03-15 Exercise |
2019-03-19 5:32 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $11 | 89,881 (Direct) |
View |
| 2019-03-15 Conversion |
2019-03-19 5:32 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $0 | 89,881 (Direct) |
View |
| 2019-03-15 Exercise |
2019-03-19 5:32 pm |
N/A 2023-06-15 |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
1,604 | $11.62 | 89,881 (Direct) |
View |
| 2019-03-15 Exercise |
2019-03-19 5:32 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
1,604 | $11.62 | 89,881 (Direct) |
View |
| 2019-03-15 Conversion |
2019-03-19 5:32 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
1,604 | $0 | 89,881 (Direct) |
View |
| 2019-03-05 Conversion |
2019-03-07 5:22 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
26,940 | $0 | 26,940 (Direct) |
View |
| 2019-03-05 Exercise |
2019-03-07 5:22 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
26,940 | $11 | 26,940 (Direct) |
View |
| 2019-03-05 Exercise |
2019-03-07 5:22 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
26,940 | $11 | 26,940 (Direct) |
View |
| 2019-03-05 Conversion |
2019-03-07 5:22 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
26,940 | $0 | 26,940 (Direct) |
View |
| 2019-03-05 Conversion |
2019-03-07 5:12 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
3,588 | $0 | 43,434 (Direct) |
View |
| 2019-03-05 Exercise |
2019-03-07 5:12 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
3,588 | $11 | 43,434 (Direct) |
View |
| 2019-03-05 Exercise |
2019-03-07 5:12 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
3,588 | $11 | 43,434 (Direct) |
View |
| 2019-03-05 Conversion |
2019-03-07 5:12 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
3,588 | $0 | 43,434 (Direct) |
View |
| 2019-03-05 Gift |
2019-03-07 5:05 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bass James Edward Director |
2,631 | $0 | 51,479 (Direct) |
View |
| 2019-02-25 Conversion |
2019-02-27 4:22 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
15,183 | $0 | 92,967 (Direct) |
View |
| 2019-02-25 Conversion |
2019-02-27 4:22 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
25,184 | $0 | 92,967 (Direct) |
View |
| 2019-02-25 Exercise |
2019-02-27 4:22 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
15,183 | $11 | 92,967 (Direct) |
View |
| 2019-02-25 Exercise |
2019-02-27 4:22 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
15,183 | $11 | 92,967 (Direct) |
View |
| 2019-02-25 Conversion |
2019-02-27 4:22 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
15,183 | $0 | 92,967 (Direct) |
View |
| 2019-02-25 Exercise |
2019-02-27 4:22 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
16,817 | $11 | 92,967 (Direct) |
View |
| 2019-02-25 Exercise |
2019-02-27 4:22 pm |
N/A 2023-06-15 |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
8,367 | $11.62 | 92,967 (Direct) |
View |
| 2019-02-25 Exercise |
2019-02-27 4:22 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
16,817 | $11 | 92,967 (Direct) |
View |
| 2019-02-25 Exercise |
2019-02-27 4:22 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
8,367 | $11.62 | 92,967 (Direct) |
View |
| 2019-02-25 Conversion |
2019-02-27 4:22 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
25,184 | $0 | 92,967 (Direct) |
View |
| 2019-02-15 Conversion |
2019-02-19 1:50 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $0 | 93,881 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-19 1:50 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $11 | 93,881 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-19 1:50 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $11 | 93,881 (Direct) |
View |
| 2019-02-15 Conversion |
2019-02-19 1:50 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $0 | 93,881 (Direct) |
View |
| 2019-02-05 Conversion |
2019-02-06 1:01 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
3,000 | $0 | 43,646 (Direct) |
View |
| 2019-02-05 Conversion |
2019-02-06 1:01 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
3,000 | $0 | 43,646 (Direct) |
View |
| 2019-01-31 Conversion |
2019-02-04 3:53 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
6,135 | $0 | 47,511 (Direct) |
View |
| 2019-01-31 Conversion |
2019-02-04 3:53 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
865 | $0 | 47,511 (Direct) |
View |
| 2019-01-31 Conversion |
2019-02-04 3:53 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
6,135 | $0 | 47,511 (Direct) |
View |
| 2019-01-31 Conversion |
2019-02-04 3:53 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
865 | $0 | 47,511 (Direct) |
View |
| 2019-01-31 Conversion |
2019-02-01 11:50 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,150 | $0 | 12,770 (Direct) |
View |
| 2019-01-31 Exercise |
2019-02-01 11:50 am |
N/A 2023-06-15 |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,150 | $11.62 | 12,770 (Direct) |
View |
| 2019-01-31 Exercise |
2019-02-01 11:50 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,150 | $11.62 | 12,770 (Direct) |
View |
| 2019-01-31 Conversion |
2019-02-01 11:50 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,150 | $0 | 12,770 (Direct) |
View |
| 2019-01-28 Exercise |
2019-01-29 3:41 pm |
N/A 2019-02-03 |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Medical Officer |
622 | $8.11 | 129,607 (Direct) |
View |
| 2019-01-28 Exercise |
2019-01-29 3:41 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Medical Officer |
622 | $8.11 | 129,607 (Direct) |
View |
| 2019-01-15 Conversion |
2019-01-16 4:26 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $0 | 97,881 (Direct) |
View |
| 2019-01-15 Exercise |
2019-01-16 4:26 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $11 | 97,881 (Direct) |
View |
| 2019-01-15 Exercise |
2019-01-16 4:26 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $11 | 97,881 (Direct) |
View |
| 2019-01-15 Conversion |
2019-01-16 4:26 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
4,000 | $0 | 97,881 (Direct) |
View |
| 2019-01-14 Conversion |
2019-01-15 11:25 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
8,620 | $0 | 12,517 (Direct) |
View |
| 2019-01-14 Exercise |
2019-01-15 11:25 am |
N/A 2023-06-15 |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
8,620 | $11.62 | 12,517 (Direct) |
View |
| 2019-01-14 Exercise |
2019-01-15 11:25 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
8,620 | $11.62 | 12,517 (Direct) |
View |
| 2019-01-14 Conversion |
2019-01-15 11:25 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
8,620 | $0 | 12,517 (Direct) |
View |
| 2019-01-11 Conversion |
2019-01-11 3:10 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
2,138 | $0 | 2,138 (Direct) |
View |
| 2019-01-11 Exercise |
2019-01-11 3:10 pm |
N/A 2019-02-03 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
180 | $8.11 | 2,138 (Direct) |
View |
| 2019-01-11 Exercise |
2019-01-11 3:10 pm |
N/A 2020-01-15 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
1,958 | $7.41 | 2,138 (Direct) |
View |
| 2019-01-11 Exercise |
2019-01-11 3:10 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
180 | $8.11 | 2,138 (Direct) |
View |
| 2019-01-11 Exercise |
2019-01-11 3:10 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
1,958 | $7.41 | 2,138 (Direct) |
View |
| 2019-01-11 Conversion |
2019-01-11 3:10 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
2,138 | $0 | 2,138 (Direct) |
View |
| 2019-01-07 Conversion |
2019-01-09 4:43 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
14,230 | $0 | 53,646 (Direct) |
View |
| 2019-01-07 Conversion |
2019-01-09 4:43 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
14,230 | $0 | 53,646 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-03 2:53 pm |
N/A 2029-01-02 |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
34,500 | $55.73 | 34,500 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-03 2:49 pm |
N/A 2029-01-02 |
REATA PHARMACEUTICALS INC | RETA | Wilson Jason Douglas CFO |
34,500 | $55.73 | 34,500 (Direct) |
View |
| 2019-01-02 Conversion |
2019-01-03 2:45 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,150 | $0 | 21,137 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-03 2:45 pm |
N/A 2023-06-15 |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,150 | $11.62 | 21,137 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-03 2:45 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,150 | $11.62 | 21,137 (Direct) |
View |
| 2019-01-02 Conversion |
2019-01-03 2:45 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,150 | $0 | 21,137 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-03 2:37 pm |
N/A 2029-01-02 |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
34,500 | $55.73 | 34,500 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-03 2:34 pm |
N/A 2029-01-02 |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Medical Officer |
35,500 | $55.73 | 35,500 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-03 2:29 pm |
N/A 2029-01-02 |
REATA PHARMACEUTICALS INC | RETA | Huff James Warren CEO |
114,500 | $55.73 | 114,500 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-03 2:25 pm |
N/A 2029-01-02 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine Principal Accounting Officer |
20,000 | $55.73 | 20,000 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-03 2:15 pm |
N/A 2029-01-02 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter VP, Chief Commercial Officer |
34,500 | $55.73 | 34,500 (Direct) |
View |
| 2018-11-13 Other |
2018-11-14 4:28 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Charles Henry Rose 2001 Trust John William Rose 2002 Trust Director, 10% Owner |
811,546 | $0 | 879,281 (Indirect) |
View |
| 2018-11-13 Other |
2018-11-14 4:28 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Charles Henry Rose 2001 Trust John William Rose 2002 Trust Director, 10% Owner |
811,546 | $0 | 879,281 (Indirect) |
View |
| 2018-11-13 Other |
2018-11-14 4:21 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Puffin Partners L.P. Puffin GP LLC Montrose Investments I L.P. Montrose Investments GP LLC Gale Charles E. Charles E. Gale Fidelity Rollover IRA Rose Evelyn P. Evelyn P. Rose Fidelity Rollover IRA Evelyn Potter Rose Survivor's Trust Director, 10% Owner |
811,546 | $0 | 879,281 (Indirect) |
View |
| 2018-11-13 Other |
2018-11-14 4:21 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Puffin Partners L.P. Puffin GP LLC Montrose Investments I L.P. Montrose Investments GP LLC Gale Charles E. Charles E. Gale Fidelity Rollover IRA Rose Evelyn P. Evelyn P. Rose Fidelity Rollover IRA Evelyn Potter Rose Survivor's Trust Director, 10% Owner |
811,546 | $0 | 879,281 (Indirect) |
View |
| 2018-11-07 Conversion |
2018-11-08 11:16 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $0 | 25,287 (Direct) |
View |
| 2018-11-07 Exercise |
2018-11-08 11:16 am |
N/A 2023-06-15 |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $11.62 | 25,287 (Direct) |
View |
| 2018-11-07 Exercise |
2018-11-08 11:16 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $11.62 | 25,287 (Direct) |
View |
| 2018-11-07 Conversion |
2018-11-08 11:16 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $0 | 25,287 (Direct) |
View |
| 2018-11-01 Conversion |
2018-11-01 5:18 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $0 | 30,037 (Direct) |
View |
| 2018-11-01 Exercise |
2018-11-01 5:18 pm |
N/A 2023-06-15 |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $11.62 | 30,037 (Direct) |
View |
| 2018-11-01 Exercise |
2018-11-01 5:18 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $11.62 | 30,037 (Direct) |
View |
| 2018-11-01 Conversion |
2018-11-01 5:18 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $0 | 30,037 (Direct) |
View |
| 2018-10-23 Conversion |
2018-10-24 11:01 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
14,250 | $0 | 34,787 (Direct) |
View |
| 2018-10-23 Exercise |
2018-10-24 11:01 am |
N/A 2023-06-15 |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
14,250 | $11.62 | 34,787 (Direct) |
View |
| 2018-10-23 Exercise |
2018-10-24 11:01 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
14,250 | $11.62 | 34,787 (Direct) |
View |
| 2018-10-23 Conversion |
2018-10-24 11:01 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
14,250 | $0 | 34,787 (Direct) |
View |
| 2018-07-05 Conversion |
2018-07-09 11:16 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $0 | 49,037 (Direct) |
View |
| 2018-07-05 Exercise |
2018-07-09 11:16 am |
N/A 2023-06-15 |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $11.62 | 49,037 (Direct) |
View |
| 2018-07-05 Exercise |
2018-07-09 11:16 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $11.62 | 49,037 (Direct) |
View |
| 2018-07-05 Conversion |
2018-07-09 11:16 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ward Keith Wayne Chief Development Officer |
4,750 | $0 | 49,037 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 08:05 am |
N/A 2028-06-13 |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director, 10% Owner |
8,000 | $39.48 | 8,000 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 08:05 am |
N/A 2028-06-13 |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director, 10% Owner |
1,844 | $26.49 | 8,000 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 06:05 am |
N/A 2028-06-13 |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Director, 10% Owner |
8,000 | $39.48 | 8,000 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 06:05 am |
N/A 2028-06-13 |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Director, 10% Owner |
1,958 | $26.49 | 8,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Fri, 26 Apr 2019 07:43:34 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |